Table of Contents
Vancomycin is a glycopeptide antibiotic primarily used to treat serious bacterial infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Understanding its mechanism of action and pharmacology is essential for pharmacy students to optimize its use and manage potential resistance.
Mechanism of Action
Vancomycin inhibits bacterial cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors. This binding prevents the cross-linking of peptidoglycan chains, which is crucial for cell wall strength and integrity. As a result, bacteria become osmotically unstable and undergo lysis.
The specific action involves blocking the transglycosylation step during cell wall synthesis, which is catalyzed by enzymes called transglycosylases. By preventing this step, vancomycin effectively halts bacterial growth and leads to cell death, especially in actively dividing bacteria.
Pharmacology Basics
Vancomycin is administered intravenously for systemic infections because of poor oral absorption. It has a large volume of distribution, primarily distributing into body fluids and tissues.
Key pharmacokinetic parameters include:
- Absorption: Poor oral absorption; typically given IV.
- Distribution: Wide, including bone, lung, and other tissues.
- Metabolism: Not extensively metabolized.
- Elimination: Primarily renal excretion through glomerular filtration.
Due to renal elimination, dosing adjustments are necessary in patients with impaired kidney function to prevent toxicity. Therapeutic drug monitoring (TDM) is recommended to maintain effective and safe serum concentrations.
Resistance and Clinical Considerations
Resistance to vancomycin can develop via thickening of the bacterial cell wall or modification of the D-Ala-D-Ala target to D-Ala-D-Lac, reducing binding affinity. This resistance is a growing concern in clinical settings.
Monitoring serum levels, renal function, and signs of toxicity is crucial during therapy. Common adverse effects include nephrotoxicity, ototoxicity, and “red man syndrome,” a histamine-mediated reaction caused by rapid infusion.
Summary
Vancomycin is a vital antibiotic for treating resistant Gram-positive infections. Its mechanism involves inhibiting bacterial cell wall synthesis by binding to D-Ala-D-Ala termini, leading to bacterial lysis. Pharmacologically, it requires careful dosing and monitoring due to its renal elimination and potential toxicity. Understanding these fundamentals helps pharmacy students optimize therapy and manage resistance.